CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Pan-Canadian Collaborative

Background

The pan-Canadian Health Technology Assessment (HTA) Collaborative (the Collaborative) was formed in 2011 to share best practices, minimize duplication of effort through the sharing of information, and identify and contribute to joint initiatives in the assessment of health technologies (medical devices, procedures, and diagnostics). Fostering collaboration among regional HTA producers is promoted as a core value and guiding principle of the Collaborative. The Collaborative engages collectively to enhance the development and use of HTA in Canada to improve patient outcomes and health system sustainability. To accomplish this, the Collaborative brings together representatives from provincial and pan-Canadian HTA producers.

Governance

The overall direction of the pan-Canadian HTA Collaborative is overseen by a steering committee composed of senior executives from Ontario Health (Quality), Institut national d’excellence en santé et en services sociaux (INESSS), the IHE‒Institute of Health Economics, the British Columbia Health Technology Review (BC-HTR), and CADTH. The steering committee oversees the identification of the strategic priorities of the Collaborative. Engagement with and participating in Collaborative initiatives is not restricted to those subsequently named. Involvement from all regional HTA producers is encouraged and it is expected that participation will depend on the availability of appropriate staff and interest in a given initiative. The formation and functioning of individual working groups are overseen by an operations committee. Secretariat support for the Collaborative is provided by CADTH.

Steering committee:

  • Dr. Luc Boileau, President and CEO, INESSS
  • Anna Greenberg, Interim President and CEO, Ontario Health (Quality)
  • Dr. Christopher McCabe, CEO and Executive Director, IHE‒Institute of Health Economics
  • Heather Davidson, Assistant Deputy Minister, BC-HTR
  • Suzanne McGurn, President and CEO, CADTH
  • Michelle Clark, Program Officer, Program Development, CADTH

Operations committee:

  • Dr. Michèle de Guise, Vice-President of Science, INESSS
  • Dr. Denis Roy, Vice-President of Strategy, INESSS
  • Nancy Sikich, Director of HTA, Ontario Health (Quality)
  • Ken Bond, Director of HTA and External Relationships, IHE‒Institute of Health Economics
  • Bing Guo, Associate Director of HTA, IHE
  • Manik Saini, Director of HTA, BC-HTR
  • Lesley Dunfield, Vice-President of Medical Devices and Clinical Interventions, CADTH
  • Laura Weeks, Director of HTA and Program Development, CADTH
  • Michelle Clark, Program Officer, Program Development, CADTH

Priority Topics

Collaborative members identified several potential joint initiatives that represent areas related to the development and use of HTA in Canada within which a collaborative approach may be beneficial. These joint initiatives are operationalized through working groups that report to the operations committee.

Three priority initiatives are currently underway:

  1. Sharing of Topics Under Consideration and Projects in Progress
  2. Harmonized Principles, Processes, and Collaborative Opportunities in the Conducting of HTA
  3. Horizon Scanning